{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:46:56Z","timestamp":1775000816933,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.soncn.2026.152147","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T04:14:47Z","timestamp":1772338487000},"page":"152147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Advanced Nurse Practitioner\u2019s Role in Hereditary Breast Cancer Clinics: A Patient-Centered Approach"],"prefix":"10.1016","volume":"42","author":[{"given":"Nichola","family":"McNamara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia Diez de los Rios de la","family":"Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inciser Seyma","family":"Pasalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-8877","authenticated-orcid":false,"given":"Memnun","family":"Seven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10549-021-06478-z","article-title":"An overview of genetic services delivery for hereditary breast cancer","volume":"191","author":"Reid","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.soncn.2026.152147_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2024.102627","article-title":"Information needs of women with BRCA mutations regarding cancer risk management and decision-making","volume":"72","author":"Polus","year":"2024","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0003","first-page":"7","article-title":"Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system","volume":"20","author":"Muessig","year":"2022","journal-title":"Hered Cancer Clin Pr"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-23-0596","article-title":"Racial disparities in accessing care along the continuum of cancer genetic service delivery","volume":"33","author":"Wagner","year":"2024","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"10","key":"10.1016\/j.soncn.2026.152147_bib0005","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.12968\/bjon.2024.0474","article-title":"Expanding role of the breast advanced nurse practitioner: mainstream pathway for genetic testing","volume":"34","author":"Davies-Crowley","year":"2025","journal-title":"Br J Nurs"},{"issue":"4","key":"10.1016\/j.soncn.2026.152147_bib0006","first-page":"2027","article-title":"Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons","volume":"29","author":"Manahan","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2020","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.soncn.2026.152147_bib0008","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2026.152147_bib0009","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate. Version 1.2026. Accessed September 2025. Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1545"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-022-08372-w","article-title":"A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1\/2 gene alteration: \u201cSo many little, little traumas could have been avoided","volume":"22","author":"Warner","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.soncn.2026.152147_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2024.108561","article-title":"A scoping review of parents\u2019 disclosure of BRCA1\/2 genetic alteration test results to underage children","volume":"131","author":"Diez de los Rios de la Serna","year":"2025","journal-title":"Patient Educ Couns"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0012","first-page":"56","article-title":"The Global Breast Cancer Initiative: A strategic collaboration to strengthen health care for noncommunicable diseases","volume":"87","author":"Anderson","year":"2021","journal-title":"Ann Glob Health"},{"key":"10.1016\/j.soncn.2026.152147_bib0013","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1186\/s12913-024-11744-z","volume":"24","author":"Dillon","year":"2024","journal-title":"BMC Health v Res"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0014","first-page":"35","article-title":"Improving cascade testing for hereditary cancer syndromes: Barriers and opportunities","volume":"9","author":"Babb de Villiers","year":"2024","journal-title":"npj Genom Med"},{"issue":"6","key":"10.1016\/j.soncn.2026.152147_bib0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12687-023-00664-w","article-title":"Genetic services survey\u2014experience of people with rare diseases and their families accessing genetic services in the Irish Republic","volume":"14","author":"Ward","year":"2023","journal-title":"J Community Genet"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0016","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41525-024-00412-0","article-title":"Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review","volume":"9","author":"Chiang","year":"2024","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.soncn.2026.152147_bib0017","unstructured":"National Cancer Control programme (Ireland). Health needs assessment for persons diagnosed with a cancer-predisposing variant of BRCA1 and BRCA2 in Ireland. 2022. Accessed August 2025. Available from: https:\/\/www.hse.ie\/eng\/serviceslist\/5\/cancerc\/onsultationsbrca-report-for-consultation.docx."},{"issue":"10","key":"10.1016\/j.soncn.2026.152147_bib0018","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjon.2020.29.10.S6","article-title":"Changing practice: moving to a specialist nurse-led service for BRCA gene testing","volume":"29","author":"Scott","year":"2020","journal-title":"Br J Nurs"},{"issue":"10","key":"10.1016\/j.soncn.2026.152147_bib0019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.JAA.0000873796.81961.da","article-title":"Genetic testing for patients at risk of hereditary breast and ovarian cancer","volume":"35","author":"DeTroye","year":"2022","journal-title":"JAAPA"},{"issue":"10","key":"10.1016\/j.soncn.2026.152147_bib0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/JXX.0000000000000648","article-title":"Nurse practitioners have a vital role in achieving health equity in clinical cancer genetics","volume":"33","author":"Fasaye","year":"2021","journal-title":"J Am Assoc Nurse Pr"},{"key":"10.1016\/j.soncn.2026.152147_bib0021","unstructured":"National Association of Nurse Practitioners in Women\u2019s Health (NPWH). Hereditary breast and ovarian cancer risk assessment: position statement. Accessed September 2025. Available at: https:\/\/cdn.ymaws.com\/npwh.org\/resource\/resmgr\/positionstatement\/2024_updates\/NPWH_PositionStatement_Hered.pdf"},{"key":"10.1016\/j.soncn.2026.152147_bib0022","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate. Version 1.2026. Accessed September 2025. Available at: https:\/\/www.nccn.org\/guidelines\/guidelinesdetail?category=2&id=1545"},{"key":"10.1016\/j.soncn.2026.152147_bib0023","unstructured":"National Institute of Clinical Excellence. Familial Breast Cancer: Classification, Care and Managing Breast Cancer and Related Risks in People With A Family History of Breast Cancer (CG164). Accessed September 2025. Available at: https:\/\/www.nice.org.uk\/guidance\/cg164\/chapter\/recommendations"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Electronic address: clinicalguidelines@ esmo.org. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.soncn.2026.152147_bib0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024: featured updates to the NCCN guidelines","volume":"21","author":"Daly","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10728-019-00381-x","article-title":"NICE and fair? Health technology assessment policy under the UK\u2019s National Institute for Health and Care Excellence, 1999\u20132018","volume":"28","author":"Charlton","year":"2020","journal-title":"Health Care Anal"},{"issue":"7","key":"10.1016\/j.soncn.2026.152147_bib0027","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.gim.2022.03.009","article-title":"Breast cancer risk stratification in women of screening age: incremental effects of adding mammographic density, polygenic risk, and a gene panel","volume":"24","author":"Evans","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.soncn.2026.152147_bib0028","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.annonc.2025.04.012","article-title":"Breast cancer germline multigene panel testing in mainstream oncology based on clinical\u2013public health utility: ESMO Precision Oncology Working Group recommendations","volume":"15","author":"Turnbull","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2026.152147_bib0029","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jso.24516","article-title":"Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit","volume":"115","author":"van Bommel","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.soncn.2026.152147_bib0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jgc4.1767","article-title":"Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1\/BRCA2 variant? A family cancer clinic evaluation","volume":"33","author":"Menko","year":"2024","journal-title":"J Genet Couns"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-015-3429-9","article-title":"HBOC multi-gene panel testing: comparison of two sequencing centers","volume":"152","author":"Schroeder","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"10.1016\/j.soncn.2026.152147_bib0032","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3390\/cancers15133420","article-title":"Overview of the genetic causes of hereditary breast and ovarian cancer syndrome in a large French patient cohort","volume":"15","author":"Bouras","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.soncn.2026.152147_bib0033","first-page":"57","article-title":"Risk-adjusted breast screening: an Australian perspective and considerations for the Western Pacific","volume":"1","author":"Nickson","year":"2025","journal-title":"Lancet Reg Health\u2013West Pac"},{"issue":"5","key":"10.1016\/j.soncn.2026.152147_bib0034","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.3802\/jgo.2022.33.e61","article-title":"Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)","volume":"33","author":"Kobayashi","year":"2022","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.soncn.2026.152147_bib0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12282-022-01342-4","article-title":"Genetic medicine is accelerating in Japan","volume":"29","author":"Hayashi","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.soncn.2026.152147_bib0036","doi-asserted-by":"crossref","unstructured":"Maier, C. B., Aiken, L. H., & Busse, R. (2018). Nurses in advanced roles in primary care: Policy levers for implementation. OECD Health Working Papers, No. 98. Paris: OECD Publishing. https:\/\/doi.org\/10.1787\/a8756593-en","DOI":"10.1787\/a8756593-en"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0037","article-title":"A global view of Nurse Practitioner roles in oncology","volume":"36","author":"Sangster-Gormley","year":"2020","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.soncn.2026.152147_bib0038","doi-asserted-by":"crossref","unstructured":"Delamaire, M. L., & Lafortune, G. Nurses in advanced roles: A description and evaluation of experiences in 12 developed countries. OECD Health Working Papers. 2010; No. 54. Paris: OECD Publishing. https:\/\/doi.org\/10.1787\/5kmbrcfms5g7-en","DOI":"10.1787\/5kmbrcfms5g7-en"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151627","article-title":"Advanced practice nursing titles and roles in cancer care: a scoping review","volume":"40","author":"Dowling","year":"2024","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/jnu.12380","article-title":"The global landscape of nursing and genomics","volume":"50","author":"Calzone","year":"2018","journal-title":"J Nurs Sch"},{"key":"10.1016\/j.soncn.2026.152147_bib0041","series-title":"Framework for the establishment of Advanced Nurse Practitioner and Advanced Midwife Practitioner posts","year":"2017"},{"issue":"21","key":"10.1016\/j.soncn.2026.152147_bib0042","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.12968\/bjon.2022.31.21.1104","article-title":"Advanced nursing practice: a review of scopes of practice in cancer care","volume":"31","author":"Carvalho","year":"2022","journal-title":"Br J Nurs"},{"key":"10.1016\/j.soncn.2026.152147_bib0043","series-title":"Standards of Proficiency for Registered Nurses","year":"2018"},{"issue":"6","key":"10.1016\/j.soncn.2026.152147_bib0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nurpra.2020.02.022","article-title":"Diversification of nurse practitioner practice: genetic cancer risk assessment","volume":"16","author":"King","year":"2020","journal-title":"J Nurse Pract"},{"issue":"4","key":"10.1016\/j.soncn.2026.152147_bib0046","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4103\/apjon.apjon_23_18","article-title":"Genetic testing: do cancer care nurses have a role?","volume":"5","author":"Lopez","year":"2018","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"4","key":"10.1016\/j.soncn.2026.152147_bib0047","first-page":"382","article-title":"Beyond BRCA: a pilot program to assess and improve knowledge of pharmacogenomic testing among advanced practitioners in a breast cancer treatment setting","volume":"7","author":"Hoffman","year":"2016","journal-title":"J Adv Pract Oncol"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0048","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JXX.0000000000000182","article-title":"Three things every nurse practitioner can do to integrate genetics into practice","volume":"31","author":"Reed","year":"2019","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1016\/j.soncn.2026.152147_bib0049","first-page":"96","article-title":"Establishing roles in genetic nursing: Interviews with Canadian nurses","author":"Bottorff","year":"2005","journal-title":"Can J Nurs Res Arch"},{"key":"10.1016\/j.soncn.2026.152147_bib0050","series-title":"Women's descriptions six months post notification of positive BRCA \u00bd genetic mutations (Unpublished PH.D Thesis)","author":"Becker","year":"2017"},{"issue":"2","key":"10.1016\/j.soncn.2026.152147_bib0051","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1188\/22.CJON.147-150","article-title":"The genetic management clinic: oncology nurses and management of hereditary cancer risk","volume":"26","author":"Hoopes","year":"2022","journal-title":"Clin J Oncol Nurs"},{"issue":"13-14","key":"10.1016\/j.soncn.2026.152147_bib0052","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1111\/jocn.16498","article-title":"Breast cancer genetic mutation: Synthesis of women's experience","volume":"32","author":"McNamara","year":"2023","journal-title":"J Clin Nurs"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151624","article-title":"Hereditary cancer syndrome carriers: feeling left in the corner","volume":"40","author":"Diez de los Rios de la Serna","year":"2024","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0054","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s10897-016-0035-x","article-title":"Reproductive decision-making in women with BRCA1\/2 mutations","volume":"26","author":"Chan","year":"2017","journal-title":"J Genet Couns"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ijgc-2018-000096","article-title":"Approach to sexual dysfunction in women with cancer","volume":"29","author":"Del Pup","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2026.152147_bib0056","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pon.4558","article-title":"Perceived influence of psychological consultation on psychological well-being, body image, and intimacy following bilateral prophylactic mastectomy: a qualitative analysis","volume":"27","author":"Glassey","year":"2017","journal-title":"Psycho-Oncol"},{"issue":"10","key":"10.1016\/j.soncn.2026.152147_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240054","article-title":"Physicians communicating with women at genetic risk of breast and ovarian cancer: are we in the middle of the ford between contradictory messages and unshared decision making?","volume":"15","author":"Fadda","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151629","article-title":"Achieving comprehensive, patient-centered cancer services: optimizing the role of advanced practice nurses in precision health","volume":"40","author":"Colomer-Lahiguera","year":"2024","journal-title":"Semin Oncol Nurs"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0059","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10689-024-00427-7","article-title":"Mainstreaming cancer genetics: feasibility of an advanced nurse practitioner-led service diagnosing Lynch syndrome from colorectal cancer in Ireland","volume":"24","author":"Loughrey","year":"2025","journal-title":"Fam Cancer"},{"issue":"2","key":"10.1016\/j.soncn.2026.152147_bib0060","first-page":"333","article-title":"Building a genomic foundation: competencies for applying genomics in oncology nursing practice","volume":"60","author":"Dickman","year":"2025","journal-title":"Nurs Clin"},{"issue":"5","key":"10.1016\/j.soncn.2026.152147_bib0061","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jnu.12993","article-title":"Update to the essential genomic nursing competencies and outcome indicators","volume":"56","author":"Calzone","year":"2024","journal-title":"J Nurs Scholarsh"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0062","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12909-019-1542-x","article-title":"Pairing pedagogical and genomic advances to prepare advanced practice nurses for the era of precision health","volume":"19","author":"Flowers","year":"2019","journal-title":"BMC Med Educ"},{"issue":"4","key":"10.1016\/j.soncn.2026.152147_bib0064","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41431-018-0311-3","article-title":"Return of individual genomic research results: are laws and policies keeping step?","volume":"27","author":"Thorogood","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.soncn.2026.152147_bib0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.socscimed.2019.02.020","article-title":"Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: the creation of an \u201concogenetic taskscape\u201d","volume":"225","author":"Wright","year":"2019","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0066","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41431-022-01212-9","article-title":"The genetic counsellor role in the United Kingdom: position on behalf of the Association of Genetic Nurses and Counsellors (AGNC), Endorsed by the Genetic Counsellor Registration Board (GCRB) and Academy for Healthcare Science (AHCS)","volume":"31","author":"Middleton","year":"2023","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.soncn.2026.152147_bib0067","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jnu.12004","article-title":"Physical, psychological and ethical issues in caring for individuals with genetic skin disease","volume":"45","author":"Seibert","year":"2013","journal-title":"J Nurs Scholarsh"},{"key":"10.1016\/j.soncn.2026.152147_bib0068","article-title":"What are the key components of an advanced nurse practitioner (ANP) led high-risk family history breast clinic? A scoping review","author":"Cadden","year":"2025","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.soncn.2026.152147_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1481948","article-title":"Consumer-oriented (patient and family) outcomes from nursing in genomics: a scoping review of the literature (2012\u20132022)","volume":"15","author":"Keels","year":"2024","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.soncn.2026.152147_bib0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djae026","article-title":"Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review","volume":"116","author":"Meernik","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.soncn.2026.152147_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12609-020-00364-1","article-title":"Disparities in genetic testing and care among black women with hereditary breast cancer","volume":"12","author":"Reid","year":"2020","journal-title":"Curr Breast Cancer Rep"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208126000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:46:50Z","timestamp":1774997210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208126000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0749208126000264"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152147","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Advanced Nurse Practitioner\u2019s Role in Hereditary Breast Cancer Clinics: A Patient-Centered Approach","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2026.152147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152147"}}